✨
AI Summary
- Taladegib improves lung fibrosis markers in idiopathic pulmonary fibrosis (IPF).
- Quantitative CT analysis from ENV-IPF-101 trial shows increased lung volume.
- Oral hedgehog pathway inhibitor shows promise for ILD.